FdaApplication
ANDA 214427
Identifiers
- fda_app_no: ANDA214427
Properties
| Property | Value |
|---|---|
| applicant_name | HANGZHOU MINSHENG BINJIANG PHARMACEUTICAL CO LTD |
| application_type | ANDA |
| approval_date | 2025-08-20 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL | 12.5MG;40MG | TABLET;ORAL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL | 12.5MG;20MG | TABLET;ORAL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL | 25MG;40MG | TABLET;ORAL |
3 products